Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis? Journal title: Pharmacological Reports Authors: Józefa Dąbek, Andrzej Kułach, Zbigniew Gąsior Subject(s):